Research Funding & Sponsorship Opportunity: Novo Nordisk Diabetes and Obesity Biologics Science Forum

Novo Nordisk is inviting a limited number of leading US academic and medical research institutions to announce this opportunity among those faculty members who could potentially have novel ideas for biologics innovation within diabetes and obesity research.

These Awards can be granted to faculty members who enter this competitive process and submit proposals for nonclinical research. Both young and established scientists at invited institutions can apply.

The areas of research in scope of the Science Forum program are:

• Non-clinical research related to new biologic therapeutics and targets amenable to biologics therapeutics or novel effects of known biologics in the field of Type 1 Diabetes and Type 2 Diabetes, including micro- and macrovascular complications, and obesity

APPLICATION DEADLINE: DECEMBER 1, 2014